Overall result forecast presentation:	yes
Quantity performed reporting year:	72
Quantity forecast year:	72
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
147	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
96	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
60	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
No care for children and young people

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Use of standardised forms for drug medical history

Organisation- und Managementhandbuch (IT-gestützt)

20.06.2022

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Organisation- und Managementhandbuch (IT-gestützt)

20.06.2022

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

im KIS implementierte Lösung

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
Krankenhausinternes Pharmakovigilanzteam

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
Krankenhausinternes Pharmakovigilanzteam

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL03 - Student training (clinical traineeship / internship year)

Explanation

FL04 - Project-related cooperation with colleges and universities

Explanation

FL02 - Lectureships / teaching posts at universities of applied sciences

Explanation

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

FL08 - Editors of scientific journals/textbooks

Explanation

FL06 - Participation in multi-centre phase III/IV studies

Explanation

FL09 - Doctoral supervision

Explanation

FL05 - Participation in multi-centre Phase I/II studies

Explanation

Training

Training in other healing professions

HB14 - Orthoptist (m/f)

Comment

HB03 - Physical therapist / physiotherapist (m/f)

Comment

Praktische Ausbildung in Kooperation mit Ausbildungseinrichtungen

HB06 - Occupational therapist (m/f)

Comment

Praktische Ausbildung in Kooperation mit Ausbildungseinrichtungen

HB20 - Nursing professional B. Sc.

Comment

in Kooperation mit der Martin-Luther-Universität Halle-Wittenberg

HB17 - Auxiliary nurse (m/f)

Comment

HB05 - Medical technical radiology assistant (MTRA) (m/f)

Comment

Praktische Ausbildung in Kooperation mit Ausbildungseinrichtungen

HB19 - Nursing professionals

Comment

HB07 - Surgical technical assistant (m/f)

Comment

HB09 - Speech therapist (m/f)

Comment

Praktische Ausbildung in Kooperation mit Ausbildungseinrichtungen

HB12 - Medical technical laboratory assistant (MTLA) (m/f)

Comment

Praktische Ausbildung in Kooperation mit Ausbildungseinrichtungen

HB13 - Medical technical assistant for functional diagnostics (MTAF) (m/f)

Comment

Praktische Ausbildung in Kooperation mit Ausbildungseinrichtungen

HB18 - Emergency paramedics (m/f) (training period 3 years)

Comment

Praktische Ausbildung in Kooperation mit Ausbildungseinrichtungen

HB15 - Anaesthesia technical assistant (m/f)

Comment

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 2
- Additional staff: 3
- Explanations: FA für Pharmakologie und Toxikologie - Anzahl: 1
- Nursing staff regulation

Service contact persons

Patient advocates

Ramona Standera

Patientenfürsprecher/in

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7050
Mail: ed.tsortsnnamgreb@rehcerpsreufnetneitap

Customer feedback management

Christian Böhme

Patientensicherheitsbeauftragter, Patientensicherheit und Feedbackmanagement

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7573
Mail: ed.tsortsnnamgreb@tnemeganamsteatilauq

Quality management

Anna Tunack

komm. Leiterin Qualitäts- und klinisches Risikomanagement

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7572
Mail: ed.tsortsnnamgreb@mq

Anna Tunack

komm. Leiterin Qualitäts- und klinisches Risikomanagement

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7572
Mail: ed.tsortsnnamgreb@mq

Hygiene officer

Dr. med. Monika Cristofolini

Krankenhaushygienikerin Fachärztin für Hygiene und Umweltmedizin Zusatzbezeichnung Infektiologie

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7259
Mail: ed.tsortsnnamgreb@inilofotsirc.akinom

Dr. med. Monika Cristofolini

Krankenhaushygienikerin Fachärztin für Hygiene und Umweltmedizin Zusatzbezeichnung Infektiologie

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7259
Mail: ed.tsortsnnamgreb@inilofotsirc.akinom

Responsible for drug therapy

PD Dr. med. habil. K. Wohlfarth

Direktor der Kliniken für Neurologie und Frührehabilitation; Leiter des lokalen Pharmakovigilanzzentrums

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7037
Mail: ed.tsortsnnamgreb@lekceaj.ttenna

Accessibility Officer

Marion Kühn

Inklusionsbeauftragte

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7562
Mail: ed.tsortsnnamgreb@nheuk.noiram

Company

General contact details of the hospital

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345-132-60
Fax: 0345-444-1338
Mail: ed.tsortsnnamgreb@ofni

Nursing service management

Henry Rafler

Pflegedirektor

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7400
Mail: ed.tsortsnnamgreb@relfar.yrneh

Head of administration

Thomas Hagdorn

Geschäftsführer

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7500
Mail: ed.tsortsnnamgreb@nrodgah.samoht

Cindy Schöne

Käufmännische Direktorin

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7501
Mail: ed.tsortsnnamgreb@eneohcs.ydnic

Responsible for the quality report in the hospital management

Thomas Hagdorn

Geschäftsführer

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-7500
Mail: ed.tsortsnnamgreb@nrodgah.samoht

Medical management

Univ.-Prof. Dr. med. Philipp Kobbe

Ärztlicher Direktor

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-6324
Mail: ed.tsortsnnamgreb@enhead.aidualc

Univ.-Prof. Dr. med. Philipp Kobbe

Ärztlicher Direktor

Merseburger Straße 165
06112 Halle (Saale)

Phone: 0345 -132-6324
Mail: ed.tsortsnnamgreb@enhead.aidualc

Regional care obligation for psychiatry?

IK number

IK: 261500553

Location number

Location number: 771678000

Old location number: 771678000

Hospital portrait for download